consortium

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

1. 50/100

   The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging

   ✓ Peer-reviewed alzhub usefulness score 50 out of 100. Nature medicine · 2025-07-15 · Caregiving

   More than 57 million people globally suffer from neurodegenerative diseases, a figure expected to double every 20 years.

   • Biomarkers
   • Treatments
   • Other Dementias
2. 48/100

   Centiloid recommendations for clinical context-of-use from the AMYPAD consortium

   ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024-11-20 · Brain scans and imaging

   Amyloid-PET quantification through the tracer-independent Centiloid (CL) scale has emerged as an essential tool for the accurate measurement of amyloid-β (Aβ) pathology in Alzheimer's disease (AD) patients.

   • Treatments
3. 43/100

   MarkVCID cerebral small vessel consortium: II. Neuroimaging protocols

   ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association · 2021-01-21 · Brain scans and imaging

   The MarkVCID consortium was formed under cooperative agreements with the National Institute of Neurologic Diseases and Stroke (NINDS) and National Institute on Aging (NIA) in 2016 with the goals of developing and validating biomarkers for the cerebral small vessel diseases associated with the vascular contributions to cognitive impairment and dementia (VCID).

   • Brain Scans
4. 48/100

   Genome-wide studies of verbal declarative memory in nondemented older people: the Cohorts for Heart and Aging Research in Genomic Epidemiology consortium

   ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Biological psychiatry · 2014-11-25 · Genetics

   This largest study to date exploring the genetics of memory function in ~40,000 older individuals revealed genome-wide associations and suggested an involvement of immune and ubiquitin pathways.

   • Genetics
5. 43/100

   Validation of the neuropathologic criteria of the third consortium for dementia with Lewy bodies for prospectively diagnosed cases

   ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Journal of neuropathology and experimental neurology · 2008-07-01 · Brain scans and imaging

   There is limited information on the validity of the pathologic criteria of the Third Consortium on Dementia with Lewy bodies (CDLB), and none are based on prospectively diagnosed cases.

   • Other Dementias
   • Brain Biology

All topic tags with their study counts